Effects of Inspiratory Muscle Training in COPD

The additional effect of inspiratory muscle training as an adjunct to a general exercise training program in patients with COPD with inspiratory muscle weakness will be studied. The main hypothesis is that inspiratory muscle training combined with an exercise training program improves functional exercise capacity more than an exercise training program without the addition of an inspiratory muscle training program.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

COPD Chronic Disease Disease Attributes Inspiratory Muscle Weakness Lung Diseases Lung Diseases, Obstructive Pathologic Processes Pathological Conditions, Signs and Symptoms Pulmonary Disease, Chronic Obstructive Respiratory Tract Diseases

Age range

40 year–90 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

University Hospital Leuven

Leuven, 3000, Belgium

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients with COPD
Eligible to participate in a exercise training intervention of 8 weeks
Pi,max <60cmH2O or <50% of the predicted normal value

Exclusion criteria

Major comorbidities preventing successful participation in an 8 week exercise training intervention

Treatment and study plan

inspiratory muscle training

Procedure

Three times daily inspiratory muscle training (2x30 breaths) at an intensity of >50% Pi,max

Primary outcomes

6-Minute Walking Distance

Time frame: Baseline and 8 weeks follow-up

Sponsors and collaborators

Lead sponsor

KU Leuven

Other

Registry information

Official study title

Effects of Inspiratory Muscle Training in Patients With Chronic Obstructive Pulmonary Disease - a Randomized Controlled Trial

Acronym: IMTCO

Important dates

Study start: 2012
Primary completion: 2016
Study completion: 2016
First posted: Jul 19, 2011
Registry last updated: Mar 14, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed